ETF UPDATE🔥: @21shares_us has just filed an S-1 update to their Injective $INJ ETF. ✅️ A target to stake 40% - 60% of the fund’s $INJ holdings, adjustable based on liquidity needs. ✅️ A proposed Nasdaq listing under TINJ. ✅️ The FTSE Injective Index as the pricing benchmark. ✅️ The BNY Mellon named as administrator, transfer agent, and cash custodian. One step closer to launch 🔥

The Innovation Exemption is the new CLARITY. The SEC’s Innovation Exemption opens a new pathway for tokenized U.S. stocks to trade onchain. Injective has built the infrastructure with the regulatory rails needed for RWAs and tokenized securities to thrive. We welcome the @SECGov’s framework, which provides temporary, conditional relief for qualifying onchain trading venues while preserving investor protections and the rights attached to the underlying shares. For American builders and institutions, this creates a concrete path to advance tokenized markets under existing law while longer-term rules take shape. Injective already brings critical capabilities to this opportunity: → SEC-registered transfer agent. Our affiliate, Injective Institutional Services, is an SEC-registered transfer agent, enabling it to maintain official securities ownership records onchain. This makes Injective the only layer-1 blockchain capable of hosting its own regulated securities onchain. → Injective Mint. The upcoming platform gives institutional issuers a single interface to create and manage assets, define eligible holders and enforce transfer restrictions directly onchain, without writing custom contracts. → Regulatory approvals for $INJ INJ today is one of the only assets to have CFTC-regulated futures. INJ is also in the final stages of gaining public ETFs. → Infrastructure built for RWA markets. Injective combines these capabilities with programmable financial infrastructure designed for sub-second settlement, giving institutions tools to build around the operational requirements of tokenized securities. This work has advanced alongside our engagement with policymakers. At the Injective Summit in Washington, D.C., U.S. Senators, Members of Congress and industry leaders came together around advancing regulatory clarity and strengthening America’s leadership in financial innovation. The SEC’s action moves that ambition forward, giving responsible innovators a practical pathway to continue building as the broader regulatory framework develops. We see the Innovation Exemption as an opportunity to connect this infrastructure to a new generation of regulated stock markets. Issuance, ownership records and trading need to work together. Injective was built in America from day one. We welcome rules that give institutions and developers like us a concrete path to build here in the heart of America. Our focus remains clear: enable everyone worldwide to access and create onchain assets. It’s time for us to create true financial freedom for all. Accelerate 🇺🇸